Risk factors for and management of ischemic-type biliary lesions following orthotopic liver transplantation:

A single center experience 

Autores: Jiang Tao, Li Chuanyun, Duan Binwei, Wang Lu, Lu Shichun, Liu Yuan

Resumen

Introduction: Biliary complications can cause morbidity, graft loss, and mortality after liver transplantation. The most troublesome biliary complications are ischemic-type biliary lesions (ITBL), which occur since transplants can now be performed after the donor has undergone circulatory death. The exact origin of this type of biliary complication remains unknown. Material and methods: A total of 528 patients were retrospectively analyzed following liver transplantation after excluding 30 patients with primary sclerosing cholangitis and those lost to follow-up from January 2007 to January 2014. The incidence of and risk factors for ITBL were evaluated. Results: Cold ischemia time (CIT) (P = 0.042) and warm ischemia time (WIT) (P = 0.006) were found to be independent risk factors for the development of ITBL. Use of the cytochrome P450 (CYP) 3A5 genotype assay to guide individualization of immunosuppressive medications resulted in significantly fewer ITBL (P = 0.027. Autoimmune hepatitis might be a risk factor for ITBL, as determined using univariate analysis (P = 0.047). Conclusions: Efforts should be taken to minimize risk factors associated with ITBL, such as CIT and WIT. The CYP3A5 genotype assay should be used to guide selection of immunosuppressive therapy in an effort to reduce the occurrence of ITBL.

Palabras clave: Biliary complications nonanastomotic strictures CyP3A5 assay.

2016-06-23   |   113 visitas   |   Evalua este artículo 0 valoraciones

Vol. 15 Núm.1. Enero-Febrero 2016 Pags. 41-46 Ann Hepatol 2016; 15(1)